Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 29, 2015
Patent Application Number
13256401
Date Filed
March 11, 2010
Patent Citations Received
Patent Primary Examiner
Patent abstract
Fusion proteins which act on the OX40/TRAIL signaling axes are provided. The proteins are useful in the treatment or amelioration of autoimmune diseases, particularly multiple sclerosis, and alloimmune diseases, as well as cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
